Oct. 8, 2019 Price forecast | 2 weeks: 7.62% | 1 month: 8.11% | 3 months: 7.07%


OVID stock forecast

Our latest prediction for Ovid Therapeutics, Inc.'s stock price was made on the Oct. 8, 2019 when the stock price was at 2.44$.

In the short term (2weeks), OVID's stock price should outperform the market by 7.62%. During that period the price should oscillate between -10.75% and +22.54%.

In the medium term (3months), OVID's stock price should outperform the market by 7.07%. During that period the price should oscillate between -23.18% and +51.81%.

Create a solid portfolio with OVID

Add OVID to your portfolio and optimize it!


About Ovid Therapeutics, Inc.

Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -1.73$ per share.

The book value per share is 2.48$

Ovid Therapeutics, Inc. website


Three months stock forecastOct. 8, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -57M - -56M -1.73 - - 33M 2.48 -45M - -45M